COEUS Holdings Launches COEMIRA, the access agency

Services will enhance and further support COEUS’ commitment to bringing innovative therapies to market

November 5, 2020 – Devon, PA – COEUS Holdings, LLC and its subsidiaries, together a leading boutique life sciences consulting firm, announced today that it has officially launched COEMIRA, the access agency. Emerging after months in stealth mode, the agency is well positioned to assist clients with increasing awareness and access to lifesaving medications. The launch of COEMIRA continues to align to COEUS’ strategic mission to provide clients with additional service offerings and optimize efforts to show true value to all stakeholders in the healthcare ecosystem.

Created based on the feedback and requests from COEUS’ current clients, COEMIRA promises to be a unique agency focused on further optimizing strategies and tactics around launching novel therapies to market and activities that drive post-launch success. COEMIRA will integrate its offerings with the capabilities and subject matter expertise found in COEUS Consulting Group, MIRADOR Global, and COEUS HealthCare.

COEUS has named industry veteran Jodie McVan to the newly created role of vice president, agency services and operations, to continue to build and lead the overall management of COEMIRA. With nearly two decades of experience focused in the agency space, Jodie brings COEMIRA a unique convergence of industry experience, agency expertise, and operational excellence. “Having an expert like Jodie on board to build and run COEMIRA allows us to hit the ground running, bringing additional support to our clients right away,” said Marc Hixson, CEO of COEUS Holdings, “we have spent the last six months integrating the agency with our other subsidiaries and have created a seamless process that will only continue to add value to our clients and the lives of their patients.”

Jodie shared “I am continually impressed by the level of knowledge and talent we have under one roof. Our in-house experts have firsthand industry experience that provides real-world perspectives that truly impacts the effectiveness of our agency recommendations.”

To learn more about COEMIRA, the access agency, and how they can enhance your therapies’ presence with key stakeholders, please visit

Founded in 2020, COEMIRA, the access agency, is a full-service content, creative, and digital agency providing ideation and execution for materials geared toward healthcare decision makers, providers, and patients. We provide the full continuum of strategic and tactical services for targeted market access and reimbursement communications. Powered by in-house expertise and market insights, we excel in identifying optimal solutions to reach the right audience with the right message at the right time.

COEMIRA understands that the evolving healthcare landscape requires agility, constant adaptation, and novel ways to effectively communicate with all stakeholders involved in the patient journey. Part of the COEUS family, COEMIRA brings nuanced expertise in clinical differentiation, access challenges, and patient services, to inform and optimize marketing efforts across stakeholders.

Our market access agency veterans know when to do things differently. We take pride in effective communication and efficient delivery, to help you maximize our client’s investment. For more information, visit

About COEUS Holdings
Founded in 2020, COEUS Holdings, LLC and its subsidiaries form a boutique life sciences market access strategic and tactical consulting firm offering clients commercial support across the entire development spectrum. COEUS teams are singularly driven to optimize market access for pharmaceutical products. We are a multi-specialty, commercially aligned consultancy, offering a comprehensive suite of informed solutions for successful engagement with organized customers, providers, and patients. Leveraging years of collective real-world market expertise, we offer unique perspectives into clinical and business opportunities to support your brands’ position in the marketplace. For more information, please visit